Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Shares of Chelsea Therapeutics (CHTP +141%) continue to soar higher on earlier reports of...

  • Wednesday, February 20, 2:42 PM ET
    Shares of Chelsea Therapeutics (CHTP +141%) continue to soar higher on earlier reports of positive FDA feedback and resubmission guidance on its Northera study. Based on the input, Chelsea plans to file a resubmission of the Northera NDA with the DCRP late in Q213. If accepted, the application will be subject to a 6-month review period.
Track new comments on this story

This news story has 2 comments:

  •  
    Excellent to have the vindication after an up-and-down ride for months. Hope the optimism does not evaporate too soon . . .
    20 Feb, 03:03 PM Reply Like
  •  
    I checked the Calendar - its not April 1
    20 Feb, 03:12 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »